Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -71.38%3.65B | 9.26%45.21B | 12.08%14.32B | -17.36%11.17B | -18.08%6.98B | 93.94%12.75B | -6.43%41.38B | 18.04%12.78B | -4.80%13.51B | -11.02%8.52B |
Net profit before non-cash adjustment | -29.21%6.03B | 7.17%24.69B | -62.83%1.85B | 17.63%7.41B | 40.41%6.91B | 24.38%8.52B | 3.57%23.04B | 53.54%4.96B | -31.41%6.3B | -4.02%4.92B |
Total adjustment of non-cash items | 35.64%3.79B | -39.27%15.05B | -15.33%11.18B | -32.32%2.4B | -120.51%-1.33B | 84.25%2.8B | 19.75%24.78B | 16.33%13.21B | 405.26%3.55B | 21.81%6.5B |
-Depreciation and amortization | 1.32%5.3B | -5.59%20.65B | -4.85%4.91B | -5.61%5.25B | -5.80%5.27B | -6.05%5.23B | 5.26%21.87B | -7.22%5.16B | 8.51%5.56B | 11.69%5.59B |
-Share of associates | -372.45%-722M | 18.89%-1.95B | -12.82%-880M | -160.17%-908M | -769.84%-422M | 119.89%265M | 0.46%-2.4B | 2.13%-780M | 38.01%-349M | 111.41%63M |
-Disposal profit | 101.19%61M | -880.30%-4.64B | 352.38%1.52B | 219.47%361M | -1,228.00%-1.41B | -25,630.00%-5.11B | -3.41%594M | -35.76%336M | 1,714.29%113M | 155.10%125M |
-Other non-cash items | -135.37%-850M | -79.24%977M | -33.66%5.64B | -29.66%-2.3B | -760.25%-4.77B | 187.67%2.4B | 176.34%4.71B | 39.95%8.5B | 54.01%-1.77B | -13.43%722M |
Changes in working capital | -530.54%-6.17B | 185.12%5.48B | 123.95%1.29B | -63.07%1.35B | 148.11%1.4B | 179.98%1.43B | -597.91%-6.43B | -43.41%-5.4B | -14.98%3.66B | -225.42%-2.91B |
-Change in receivables | -29.66%16.47B | -180.88%-2.42B | -75.76%2.01B | 42.93%-11.1B | -652.94%-16.75B | 43.14%23.42B | 115.62%2.99B | 379.71%8.3B | 30.05%-19.44B | -179.17%-2.23B |
-Change in inventory | 112.57%528M | 42.04%-2.33B | 4.87%3.01B | 18.79%-1.15B | 100.42%16M | -151.17%-4.2B | -221.01%-4.02B | 206.29%2.87B | -162.88%-1.42B | -172.17%-3.79B |
-Change in payables | -30.33%-23.17B | 288.98%10.22B | 77.47%-3.73B | -44.54%13.6B | 482.56%18.14B | -7.90%-17.78B | -131.60%-5.41B | -855.97%-16.57B | -17.81%24.52B | 139.83%3.11B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 5.69%1.04B | 68.29%1.14B | -5.26%18M | 126.67%34M | 77.97%105M | 68.21%984M | -2.45%678M | -24.00%19M | 7.14%15M | 1,375.00%59M |
Interest paid (cash flow from operating activities) | 13.73%-132M | 33.55%-602M | 44.44%-180M | 31.11%-93M | 19.27%-176M | 33.19%-153M | -2.26%-906M | -14.08%-324M | 8.16%-135M | 20.15%-218M |
Interest received (cash flow from operating activities) | 64.71%28M | 84.00%92M | 50.00%27M | 53.33%23M | 150.00%25M | 142.86%17M | 61.29%50M | 200.00%18M | 66.67%15M | 25.00%10M |
Tax refund paid | -7.67%-5.24B | -76.58%-11.3B | 99.08%-4M | -29.75%-3.26B | -522.35%-3.17B | -65.35%-4.86B | -55.86%-6.4B | -3,453.85%-436M | 10.60%-2.51B | -117.72%-510M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | -107.47%-652M | -0.75%34.54B | 17.65%14.18B | -27.77%7.87B | -52.20%3.76B | 118.60%8.73B | -12.90%34.8B | 13.88%12.05B | -3.23%10.9B | -35.53%7.86B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -117.86%-4.09B | 1,358.67%17.79B | -118.93%-1.48B | 20.34%-2.32B | 51.30%-1.34B | 743.49%22.92B | 85.74%-1.41B | 564.92%7.81B | 18.39%-2.92B | -21.12%-2.74B |
Net intangibles purchase and sale | 11.38%-1.36B | -62.70%-4.52B | 16.00%-798M | -27.61%-1.15B | -120.90%-1.04B | -235.08%-1.54B | -56.00%-2.78B | -89.62%-950M | -212.11%-902M | -4.22%-469M |
Net investment product transactions | -2,368.80%-9.26B | -52.49%-1.87B | 299.06%424M | -1,544.26%-1B | -63.17%-917M | 4.09%-375M | -180.35%-1.23B | -210.94%-213M | -27.08%-61M | -152.72%-562M |
Advance cash and loans provided to other parties | 96.77%-4M | 33.17%-546M | --0 | -124.47%-422M | --0 | 53.03%-124M | -9.08%-817M | 21.65%-199M | 21.67%-188M | -20.29%-166M |
Repayment of advance payments to other parties and cash income from loans | 83.67%90M | -63.77%342M | -92.14%25M | -0.45%219M | -70.48%49M | -79.58%49M | 15.83%944M | 13.98%318M | -1.35%220M | 12.93%166M |
Net changes in other investments | 228.66%9.79B | -945.93%-17.79B | 43.77%-221M | -63.90%-336M | -616.26%-9.62B | -1,009.20%-7.61B | 245.84%2.1B | 80.08%-393M | 3.30%-205M | 112.30%1.86B |
Investing cash flow | -136.31%-4.84B | -106.99%-6.6B | -132.16%-2.05B | -23.79%-5.02B | -574.11%-12.86B | 470.19%13.32B | 83.31%-3.19B | 261.81%6.37B | 67.68%-4.05B | -3,035.38%-1.91B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 116.40%1.82B | 37.25%-12.02B | 84.43%-669M | 100.72%74M | 97.92%-314M | -205.66%-11.12B | -13,500.70%-19.16B | -506.06%-4.3B | -1,177.95%-10.32B | -545.67%-15.07B |
Net common stock issuance | ---210M | --0 | --0 | --0 | --0 | --0 | -4,100.00%-42M | 0.00%-1M | ---41M | --0 |
Increase or decrease of lease financing | 1.96%-2.74B | 4.64%-10.82B | 7.39%-2.4B | 7.31%-2.76B | 2.79%-2.86B | 1.24%-2.8B | 0.11%-11.35B | 13.66%-2.59B | -7.54%-2.98B | -5.41%-2.94B |
Cash dividends paid | -7.69%-3.16B | -6.14%-5.88B | --0 | -8.37%-2.94B | --0 | -4.00%-2.94B | 3.92%-5.54B | --0 | -4.35%-2.71B | --0 |
Cash dividends for minorities | -305.97%-1.84B | 51.02%-813M | --0 | --0 | -150.69%-361M | 70.18%-452M | -156.97%-1.66B | --0 | --0 | ---144M |
Net other fund-raising expenses | ---- | ---383M | --0 | --0 | --1M | ---384M | ---- | ---- | ---- | ---- |
Financing cash flow | 65.34%-6.13B | 20.75%-29.92B | 55.49%-3.06B | 64.93%-5.63B | 80.53%-3.54B | -628.79%-17.69B | -114.17%-37.75B | -85.80%-6.88B | -263.62%-16.05B | -254.16%-18.16B |
Net cash flow | ||||||||||
Beginning cash position | -5.97%30.1B | -16.08%32.01B | 2.62%20.99B | -19.93%23.79B | -13.09%36.44B | -16.08%32.01B | 9.48%38.15B | -41.77%20.45B | -27.18%29.71B | 24.47%41.93B |
Current changes in cash | -366.00%-11.62B | 67.73%-1.98B | -21.41%9.07B | 69.87%-2.77B | -3.55%-12.64B | 16.76%4.37B | -290.80%-6.14B | 292.15%11.54B | -61.78%-9.21B | -271.33%-12.21B |
Effect of exchange rate changes | -25.00%42M | 1,083.33%71M | ---- | ---- | 20.00%-4M | 40.00%56M | -93.10%6M | ---- | ---- | ---5M |
End cash Position | -49.16%18.53B | -5.97%30.1B | -5.97%30.1B | 2.62%20.99B | -19.93%23.79B | -13.09%36.44B | -16.08%32.01B | -16.08%32.01B | -41.77%20.45B | -27.18%29.71B |
Free cash flow | -236.17%-6.26B | 1.82%20.17B | 36.33%11.49B | -36.92%4.33B | -105.33%-246M | 4,649.50%4.6B | -27.02%19.81B | 5.65%8.43B | -4.33%6.87B | -50.24%4.62B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |